{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"9"}],"units":"Participants"}],"groups":[{"description":"Mobilization with Filgrastim Stem Cell Collection Bortezomib Melphalan Stem Cell infusion\n\nfilgrastim: 16 mcg/kg daily beginning 3 days before Stem Cell Collection through day before final Stem Cell Collection\n\nbortezomib: 1.0 mg/m2/dose D -6, D-3, D +1, D + 4\n\nmelphalan: 100 mg/m2/dose D -2, D -1\n\nStem Cell Infusion: infusion of previously collected autologous stem cells","id":"OG000","title":"Stem Cell Transplantation With Bortezomib and Melphalan"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"one year from transplant","title":"Number of Participants Surviving at 1 Year","type":"SECONDARY","unitOfMeasure":"participants"}